Recombinant Human CTHRC1 protein (rFc Tag)
Species
Human
Purity
>90 %, SDS-PAGE
Tag
rFc Tag
Activity
not tested
Cat no : Eg2824
Validation Data Gallery
Product Information
Purity | >90 %, SDS-PAGE |
Endotoxin | <0.1 EU/μg protein, LAL method |
Activity |
Not tested |
Expression | HEK293-derived Human CTHRC1 protein Ser31-Lys243 (Accession# Q96CG8-1) with a rabbit IgG Fc tag at the C-terminus. |
GeneID | 115908 |
Accession | Q96CG8-1 |
PredictedSize | 49.1 kDa |
SDS-PAGE | 46-55 kDa, reducing (R) conditions |
Formulation | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage Conditions |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
CTHRC1 is a secreted glycoprotein that plays a pivotal role in extracellular matrix (ECM) deposition and wound repair. CTHRC1 is present in normal tissues and organs, and it has vital functions in physiological processes, including participating in the regulation of metabolism, arterial remodeling, bone formation and myelination of the peripheral nervous system. It has been reported that abnormal expression of CTHRC1 is involved in the carcinogenesis of various human organs, such as the breast, colon, pancreas, lung, stomach and liver.
References:
1.Mei D. et al. (2020) Mediators Inflamm. 2020:9578701. 2.Myngbay A. et al. (2021) Int J Mol Sci. 22(5):2426. 3.Liu YJ. et al. (2023) Oncol Lett. 25(6):266. 4.Mukhatayev Z. et al. (2024) Cells. 13(11):946.